The American Journal of Managed Care > May 2012
The American Journal of Managed Care - May 2012
May 23, 2012 – Sara P. Bilir, MS; Mitchell P. DeKoven, MHSA; and Juliet Munakata, MS
Use of bioimpedance spectroscopy to aid in post“breast cancer assessments for lymphedema can be cost saving for healthcare organizations in the United States.
May 08, 2012 – Stephanie A. Stowell, MPhil; Allison J. Gardner, PhD; Joseph S. Alpert, MD; Gerald V. Naccarelli, MD; Thomas P. Harkins, MA, MPH; Anthony M. Louder, PhD, RPh; and Leonardo Tamariz, MD, MPH
Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.
May 21, 2012 – Marcia M. Ward, PhD; Smruti Vartak, PhD; Jean L. Loes, RN, BSN, MS; John O'Brien, MBA; Troy R. Mills, MS; Jonathon R. B. Halbesleben, PhD; and Douglas S. Wakefield, PhD
This study examines staff perceptions of patient care quality and the processes before and after implementation of a comprehensive clinical information system in 7 critical access hospitals.
May 08, 2012 – Joel F. Farley, PhD; Daryl Wansink, PhD; Jennifer H. Lindquist, MStat; John C. Parker, PhD; and Matthew L. Maciejewski, PhD
Value-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
May 08, 2012 – Keith C. Bible, MD, PhD; Robert C. Smallridge, MD; John C. Morris, MD; Julian R. Molina, MD; Vera J. Suman, PhD; John A. Copland, PhD; Joseph Rubin, MD; Michael E. Menefee, MD; Kostandinos Sideras, MD
The development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.
May 09, 2012 – Carrie H. Colla, PhD; Nancy E. Morden, MD, MPH; Jonathan S. Skinner, PhD; J. Russell Hoverman, MD, PhD; and Ellen Meara, PhD
Payment reform may be used to better align appropriate financial incentives with better quality of care.
May 09, 2012 – Grace Wang, PhD, MPH; Miriam Kuppermann, PhD, MPH; Benjamin Kim, MD, PhD; Kathryn A. Phillips, PhD; and Uri Ladabaum, MD, MS
This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.
Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
May 09, 2012 – Joseph C. Hodges, MD, MBA; Yair Lotan, MD; Thomas P. Boike, MD; Rhonda Benton, BS, CMC; Alyson Barrier, BBA; and Robert D. Timmerman, MD
Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.
May 09, 2012 – Rena M. Conti, PhD; Meredith B. Rosenthal, PhD; Blase N. Polite, MD; Peter B. Bach, MD, MAPP; and Ya-Chen Tina Shih, PhD
As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.
Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences
May 09, 2012 – Marc L. Fishman, MD; Akhil Kumar, MD; Sharon Davis, MPH; William Shimp, MD; and William J. M. Hrushesky, MD, FACP
Active expert peer-to-peer consultation with prescribing oncologists can promote adherence to guidelines and lead to cost reductions without risk of neutropenic fever, with or without hospitalization, for patients with cancer.
Implementation of Cancer Clinical Care Pathways: A Successful Model of Collaboration Between Payers and Providers
May 18, 2012 – Bruce A. Feinberg, DO; James Lang, PharmD, MBA; James Grzegorczyk, MS, RPh; Donna Stark, RPh, MBA; Thomas Rybarczyk, RN, BSN; Thomas Leyden, MBA; Joseph Cooper; Thomas Ruane, MD; Scott Milligan, PhD; Philip Stella, MD; and Jeffrey A. Scott, MD
A statewide collaboration between payers and providers to create a cancer clinical care pathways program is successful.